These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 457336)

  • 1. Synthesis and some pharmacological properties of [Glu(OMe)4]oxytocin and [Mpr1, Glu(OMe)4]oxytocin.
    Photaki I; Tzougraki C; Kotsira-Engonopoulos C
    Int J Pept Protein Res; 1979 Apr; 13(4):426-33. PubMed ID: 457336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
    Bodanszky M; Fagan DT; Walter R; Smith CW
    J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the importance of the asparagine residue in oxytocin. Synthesis and some pharmacological properties of [1-alpha-mercaptoacetic acid, 5-isoasparagine] oxytocin.
    Roy J; Johnson M; Dubin S; Gazis DC; Schwartz IL
    Int J Pept Protein Res; 1980 Mar; 15(3):279-84. PubMed ID: 6985566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
    Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
    J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [4-(0-methyl)-L-threonine] -oxytocin. Synthesis and uterotonic activity.
    Bańkowski K
    Pol J Pharmacol Pharm; 1988; 40(3):331-5. PubMed ID: 2853867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin analogs with substitutions in postions 3 and 4.
    Roy J; Havran RT; Schwartz IL; Walter R
    Int J Pept Protein Res; 1975; 7(2):171-8. PubMed ID: 1140889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of oxytocin and lysine vasopressin analogs containing glutamic acid gamma-hydrazide in position 4.
    Gazis D; Glass J; Schwartz IL; Stavropoulos G; Theodoropoulos D
    Int J Pept Protein Res; 1989 Nov; 34(5):353-7. PubMed ID: 2613436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
    Smith CW; Ferger MF
    J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and some pharmacological properties of (2-L-DOPA)-oxytocin.
    Ferrier BM; Branda LA
    Can J Biochem; 1976 May; 54(5):507-11. PubMed ID: 1276975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin.
    Roy U; Gazis D; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and some biological properties of 1-deamino-4-glu-oxytocin (1-beta-mercaptopropionic acid-4-glutamic acid-oxytocin) and its use in preparing a hormone-agarose complex.
    Ferrier BM; Branda LA
    Can J Biochem; 1975 Jan; 53(1):21-7. PubMed ID: 1120287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.